York Michael 4
4 · Metacrine, Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Metacrine, Inc.MTCR
York Michael
Chief Business Officer
Transactions
- Award
Stock option (right to buy)
2022-02-27+210,553→ 210,553 totalExercise: $0.47Exp: 2032-02-26→ Common Stock (210,553 underlying) - Award
Common Stock
2022-02-27+210,553→ 210,553 total
Footnotes (2)
- [F1]Represents the number of shares of Common Stock issued to the Reporting Person pursuant to an award of restricted stock units. The award vests in full on February 27, 2023, subject to the Reporting Person's continued service to the Issuer.
- [F2]50% of the shares of Common Stock subject to the stock option shall vest and become exercisable on February 27, 2023, and the remaining shares shall vest and become exercisable in equal installments on the last day of each of the following 12 months until fully vested on February 27, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.